Of mice and men: terminal complement inhibition with anti-C5 monoclonal antibodies.
E S
ES
Woodle
W M
WM
Baldwin
D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology / Q000627:therapeutic use*; D003182:Complement C5 / Q000276:immunology*; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology; D051379:Mice
D061067:Antibodies, Monoclonal, Humanized; D003182:Complement C5; C481642:eculizumab